Antimicrobial Activity of Exebacase (Lysin CF-301) against the Most Common Causes of Infective Endocarditis

Aubrey Watson, Jun Taek Oh, Karen Sauve, Patricia A. Bradford, Cara Cassino, Raymond Schuch

Antimicrobial Agents and Chemotherapy · 2019 · 38 citations · 28 references

DOIFull text

Open access

Concepts

Abstract

Exebacase, a recombinantly produced lysin (cell wall hydrolase), and comparator antibiotics were tested by the broth microdilution method against strain sets of Staphylococcus and Streptococcus spp., which are the most common causes of infective endocarditis in humans. Exebacase was active against all Staphylococcus spp. tested, including S. aureus and coagulase-negative staphylococci (MIC 50/90 , 0.5/1 μg/ml). Activity against Streptococcus spp.

References

28